` 1YR (Immunovia AB (publ)) vs DAX Index Comparison - Alpha Spread

1YR
vs
D
DAX Index

Over the past 12 months, 1YR has underperformed DAX Index, delivering a return of -98% compared to the DAX Index's +14% growth.

Stocks Performance
1YR vs DAX Index

Loading
1YR
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
1YR vs DAX Index

Loading
1YR
DAX Index
Difference
www.alphaspread.com

Performance By Year
1YR vs DAX Index

Loading
1YR
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Immunovia AB (publ) vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Immunovia AB (publ)
Glance View

Market Cap
7.6k EUR
Industry
Health Care

Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. The company is headquartered in Lund, Skane and currently employs 65 full-time employees. The company went IPO on 2015-12-01. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.

1YR Intrinsic Value
0.0001 EUR
Undervaluation 32%
Intrinsic Value
Price €0.0001
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett